Myeloid progenitor cells in the premetastatic lung promote … · 2012. 1. 24. · Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.
Dingcheng Gao1,2, Natasha Joshi1,2, Hyejin Choi1,2, Seongho Ryu1,2, Mary Hahn1,2, Raul Catena1,2, Helen Sadik6, Pedram Argani6, Patrick Wagner3, Linda T. Vahdat4, Jeffrey L. Port1, Brendon Stiles1, Saraswati Sukumar6, Nasser K. Altorki1, Shahin Rafii5 and Vivek Mittal1,2
1Department of Cardiothoracic Surgery and Neuberger Berman Lung Cancer Center 2Department of Cell and Developmental Biology 3Department of Pathology 4Department of Medicine 5HHMI, Department of Genetic Medicine
Weill Cornell Medical College of Cornell University 1300 York Avenue 525 East 68th street New York, New York 10065
6Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1650 Orleans Street, Baltimore, MD 21231-1000
Key words: Bone marrow, Myeloid cells, Metastasis, Ly6C, Versican, Mesenchymal to epithelial transition
Correspondence: Vivek Mittal Weill Cornell Medical College of Cornell University 1300 York Avenue, Room 603C New York, NY 10065 Dingcheng Gao Weill Cornell Medical College of Cornell University 1300 York Avenue, Room 603A New York, NY 10065
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
References: 1. Townson JL, Chambers AF. Dormancy of solitary metastatic cells. Cell Cycle. 2006;5:1744-50. 2. Naumov GN, Bender E, Zurakowski D, Kang SY, Sampson D, Flynn E, et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst. 2006;98:316-25. 3. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679-95. 4. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239-52. 5. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265-73. 6. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3:453-8. 7. Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the 'pre-metastatic niche': within bone and beyond. Cancer Metastasis Rev. 2006;25:521-9. 8. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. 2008;319:195-8. 9. Chaffer CL, Thompson EW, Williams ED. Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs. 2007;185:7-19. 10. Dutt S, Cassoly E, Dours-Zimmermann MT, Matasci M, Stoeckli ET, Zimmermann DR. Versican V0 and V1 direct the growth of peripheral axons in the developing chick hindlimb. J Neurosci. 2011;31:5262-70. 11. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992;12:954-61. 12. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S, et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 2007;21:1546-58. 13. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol. 2002;14:617-23. 14. Ricciardelli C, Brooks JH, Suwiwat S, Sakko AJ, Mayne K, Raymond WA, et al. Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin Cancer Res. 2002;8:1054-60. 15. Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P, Kosma VM, et al. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res. 2004;10:2491-8. 16. Pukkila M, Kosunen A, Ropponen K, Virtaniemi J, Kellokoski J, Kumpulainen E, et al. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma. J Clin Pathol. 2007;60:267-72. 17. Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Ojima Y, et al. Prognostic significance of stromal versican expression in human endometrial cancer. Ann Oncol. 2007;18:269-74.
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
18. Pirinen R, Leinonen T, Bohm J, Johansson R, Ropponen K, Kumpulainen E, et al. Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. Hum Pathol. 2005;36:44-50. 19. Pukkila MJ, Kosunen AS, Virtaniemi JA, Kumpulainen EJ, Johansson RT, Kellokoski JK, et al. Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study. J Clin Pathol. 2004;57:735-9. 20. Krystal G, Sly L, Antignano F, Ho V, Ruschmann J, Hamilton M. Re: the terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007;67:3986. 21. Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007;67:425; author reply 6. 22. Coffelt SB, Lewis CE, Naldini L, Brown JM, Ferrara N, De Palma M. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol. 2010;176:1564-76. 23. Ricciardelli C, Sakko AJ, Ween MP, Russell DL, Horsfall DJ. The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev. 2009;28:233-45. 24. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 1989;8:2975-81. 25. Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng PS, et al. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell. 2005;16:1330-40. 26. Padua D, Massague J. Roles of TGFbeta in metastasis. Cell Res. 2009;19:89-102. 27. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685-700. 28. Song J. EMT or apoptosis: a decision for TGF-beta. Cell Res. 2007;17:289-90. 29. Hata A, Shi Y, Massague J. TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. Mol Med Today. 1998;4:257-62. 30. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. J Cell Physiol. 2007;213:374-83. 31. Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 2006;66:11271-8. 32. Kowanetz M, Wu X, Lee J, Tan M, Hagenbeek T, Qu X, et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci U S A. 2010;107:21248-55. 33. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 2009;15:35-44. 34. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell. 2008;13:23-35. 35. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol. 2009;182:4499-506. 36. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 2008;181:5791-802.
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
37. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature. 2009;457:102-6. 38. Vainio S, Lin Y. Coordinating early kidney development: lessons from gene targeting. Nat Rev Genet. 2002;3:533-43. 39. Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, et al. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol. 2009;22:668-78. 40. Mur C, Martínez-Carpio PA, Fernández-Montolí ME, Ramon JM, Rosel P, Navarro MA. Growth of MDA-MB-231 cell line: different effects of TGF-beta(1), EGF and estradiol depending on the length of exposure. Cell Biol Int. 1998;22:679-84. 41. Zugmaier G, Ennis BW, Deschauer B, Katz D, Knabbe C, Wilding G, et al. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines. J Cell Physiol. 1989;141:353-61.
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905
Published OnlineFirst January 26, 2012.Cancer Res Dingcheng Gao, Natasha Joshi, Hyejin Choi, et al. metastases by inducing mesenchymal to epithelial transition.Myeloid progenitor cells in the premetastatic lung promote
Updated version
10.1158/0008-5472.CAN-11-2905doi:
Access the most recent version of this article at:
To order reprints of this article or to subscribe to the journal, contact the AACR Publications
Permissions
Rightslink site. Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC)
.http://cancerres.aacrjournals.org/content/early/2012/01/24/0008-5472.CAN-11-2905To request permission to re-use all or part of this article, use this link
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 26, 2012; DOI: 10.1158/0008-5472.CAN-11-2905